DrugPatentWatch Database Preview
CENTANY Drug Profile
» See Plans and Pricing
When do Centany patents expire, and when can generic versions of Centany launch?
Centany is a drug marketed by Perrigo New York and is included in one NDA.
The generic ingredient in CENTANY is mupirocin. There are sixteen drug master file entries for this compound. Twenty suppliers are listed for this compound. Additional details are available on the mupirocin profile page.
US ANDA Litigation and Generic Entry Outlook for Centany
A generic version of CENTANY was approved as mupirocin by PERRIGO ISRAEL on November 7th, 2003.
Summary for CENTANY
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 2 |
| Bulk Api Vendors: | 72 |
| Clinical Trials: | 2 |
| Patent Applications: | 5,791 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for CENTANY |
| DailyMed Link: | CENTANY at DailyMed |
Recent Clinical Trials for CENTANY
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| St. Louis Children's Hospital | Phase 2 |
| University of Washington | Phase 2 |
| Indiana University | Phase 2 |
Pharmacology for CENTANY
| Drug Class | RNA Synthetase Inhibitor Antibacterial |
| Mechanism of Action | RNA Synthetase Inhibitors |
US Patents and Regulatory Information for CENTANY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo New York | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | BX | RX | No | No | Start Trial | Start Trial | Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for CENTANY
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Perrigo New York | CENTANY | mupirocin | OINTMENT;TOPICAL | 050788-001 | Dec 4, 2002 | Start Trial | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
International Patents for CENTANY
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 0933081 | Start Trial |
| Canada | 2259764 | Start Trial |
| Israel | 123143 | Start Trial |
| Germany | 69900561 | Start Trial |
| >Country | >Patent Number | >Estimated Expiration |
